Engineered Drug Resistant γδ T Cells Kill Glioblastoma Cell Lines during a Chemotherapy Challenge: A Strategy for Combining Chemo- and Immunotherapy

Classical approaches to immunotherapy that show promise in some malignancies have generally been disappointing when applied to high-grade brain tumors such as glioblastoma multiforme (GBM). We recently showed that ex vivo expanded/activated γδ T cells recognize NKG2D ligands expressed on malignant g...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Lamb, Lawrence S., Bowersock, Joscelyn, Dasgupta, Anindya, Gillespie, G. Yancey, Su, Yun, Johnson, Austin, Spencer, H. Trent
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2013
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3543433/
https://ncbi.nlm.nih.gov/pubmed/23326319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0051805
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi